Chemcon Special.
NSE: CHEMCON · Specialty Chemicals
Snapshot
Unlock Chemcon Special.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Chemcon Speciality Chemicals Limited is a manufacturer of pharmaceutical intermediates, silanes, and oilfield chemicals based in Vadodara, India. The company serves a global client base across multiple international markets, providing both proprietary chemical products and contract manufacturing services.
Business Model
The company generates revenue through the production and sale of specialised chemical compounds used in the pharmaceutical and oilfield sectors. It also leverages its manufacturing capabilities to provide contract manufacturing services to third-party clients.
Growth Outlook
Growth is driven by the expansion of its pharmaceutical intermediate portfolio and the sustained demand for oilfield chemicals in global markets. The company continues to focus on its export footprint to diversify its revenue streams.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical raw materials can significantly impact the company's operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate high capital expenditure for compliance.
- Geopolitical and Export Risks. As a significant exporter, the company is exposed to trade barriers, currency fluctuations, and geopolitical instability in its target international markets.
- Client Concentration. Dependence on a limited number of large customers in the pharmaceutical and oilfield sectors poses a risk to revenue stability.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Chemcon Special. and 5,000+ companies — free.
Key Metrics
REVENUE
₹240 Cr
TTM · standalone
NET PROFIT
₹24 Cr
TTM · standalone
EPS
₹6.44
TTM · standalone
RETURN ON EQUITY
4.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
6.8%
TTM · standalone
P/E
28.6x
Q4 FY26 · standalone
EV/EBITDA
15.7x
Q4 FY26 · standalone
EBITDA MARGIN
19.0%
TTM · standalone
NET PROFIT MARGIN
8.4%
Q4 FY26 · standalone
DEBT TO EQUITY
0.1x
Q4 FY26 · standalone
Peers · Specialty Chemicals
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Chemcon Special.CHEMCON | 519 | 28.61 | 15.73 | 15.7% | 19.0% | 4.8% | 6.8% | -11.3% |
Fairchem OrganicFAIRCHEMOR | 615 | 159.20 | 42.20 | -14.5% | 5.0% | 2.0% | 3.6% | -26.4% |
AmalAMAL | 574 | 34.61 | 20.39 | 77.1% | 15.8% | 21.4% | 26.8% | -37.1% |
Sudarshan PharmaSUDARSHAN | 548 | 41.13 | 20.86 | — | 8.5% | 15.1% | 30.3% | +38.0% |
Jayant Agro Org.JAYAGROGN | 510 | — | — | -47.4% | -1.7% | -9.3% | -8.8% | -16.9% |
DMCC Speciality Chemicals Ltd.DMCC | 507 | 24.60 | 11.76 | 34.8% | 11.1% | 11.7% | 17.7% | -15.2% |
As of Q4 FY26
Financials
Chemcon Special.
NSE: CHEMCON · Specialty Chemicals
Snapshot
Unlock Chemcon Special.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Chemcon Speciality Chemicals Limited is a manufacturer of pharmaceutical intermediates, silanes, and oilfield chemicals based in Vadodara, India. The company serves a global client base across multiple international markets, providing both proprietary chemical products and contract manufacturing services.
Business Model
The company generates revenue through the production and sale of specialised chemical compounds used in the pharmaceutical and oilfield sectors. It also leverages its manufacturing capabilities to provide contract manufacturing services to third-party clients.
Growth Outlook
Growth is driven by the expansion of its pharmaceutical intermediate portfolio and the sustained demand for oilfield chemicals in global markets. The company continues to focus on its export footprint to diversify its revenue streams.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical raw materials can significantly impact the company's operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate high capital expenditure for compliance.
- Geopolitical and Export Risks. As a significant exporter, the company is exposed to trade barriers, currency fluctuations, and geopolitical instability in its target international markets.
- Client Concentration. Dependence on a limited number of large customers in the pharmaceutical and oilfield sectors poses a risk to revenue stability.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Chemcon Special. and 5,000+ companies — free.
Key Metrics
REVENUE
₹240 Cr
TTM · standalone
NET PROFIT
₹24 Cr
TTM · standalone
EPS
₹6.44
TTM · standalone
RETURN ON EQUITY
4.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
6.8%
TTM · standalone
P/E
28.6x
Q4 FY26 · standalone
EV/EBITDA
15.7x
Q4 FY26 · standalone
EBITDA MARGIN
19.0%
TTM · standalone
NET PROFIT MARGIN
8.4%
Q4 FY26 · standalone
DEBT TO EQUITY
0.1x
Q4 FY26 · standalone
Peers · Specialty Chemicals
As of Q4 FY26